Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion type Assertion NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_head.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion description "[Current therapy of haemophilia is based on factor VIII (FVIII) or factor IX (FIX) replacement therapy including prophylactic or demand protocols of fixed-dose, and as future alternative, gene and cell therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion evidence source_evidence_literature NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion SIO_000772 21396685 NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion wasDerivedFrom befree-20150227 NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.
- NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_assertion wasGeneratedBy ECO_0000203 NP392688.RAnOw-CJbVnSZDbHwwI451WhC3Qj9qhuBXIO8z4sC04_M130_provenance.